Atlas Trials

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency

Clinical trial NCT06432140 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06432140
Sponsor
Shanghai Vitalgen BioPharma Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aromatic L-amino Acid Decarboxylase Deficiency
Start date
2024-07-02
Primary completion
2026-07-23
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.